Filing Flows › Paysign (PAYS) › Q2 2026 › vs Q1 2026
Paysign (PAYS) Q2 2026 vs Q1 2026 (quarter over quarter)
Paysign's revenue rose $214K (+0.8%) from $28.0M in Q1 2026 to $28.3M in Q2 2026. The biggest changes: Plasma Industry +$1.3M (+11%); Pharma Industry −$1.0M (-7%); Other Revenue −$48K (-8%). Gross margin 63.3% against 65.0% (-1.6 pts).
Paysign, Q2 2026: revenue $28.3M (+48% year over year), operating margin 24.8%, net earnings $6.8M, operating cash flow $1.3M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 63.3% | 65.0% | -1.6 pts |
| Operating margin | 24.8% | 23.8% | +1.0 pts |
| Net margin | 23.9% | 19.4% | +4.5 pts |
| Free cash flow margin | 4.2% | 66.0% | -61.8 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Pharma Industry | $14.6M | $15.7M | −$1.0M | -7% |
| Plasma Industry | $13.0M | $11.7M | $1.3M | +11% |
| Other Revenue | $562K | $610K | −$48K | -8% |
| Breakage Revenue | $76K | $112K | −$36K | -32% |
| Revenue | $28.3M | $28.0M | $214K | +0.8% |
| Gross profit | $17.9M | $18.2M | −$322K | -2% |
| Cost of revenue | $10.4M | $9.8M | $536K | +5% |
| Other income, net | $894K | $801K | $93K | +12% |
| Operating profit | $7.0M | $6.7M | $343K | +5% |
| Operating expenses | $10.9M | $11.6M | −$665K | -6% |
| Pre-tax earnings | $7.9M | $7.5M | $436K | +6% |
| SG&A | $8.5M | $8.9M | −$368K | -4% |
| Other operating costs | $2.3M | $2.6M | −$296K | -11% |
| Net earnings | $6.8M | $5.4M | $1.3M | +24% |
| Income tax | $1.1M | $2.0M | −$881K | -43% |
| Operating cash sources | $10.3M | $9.4M | $990K | +11% |
| Depreciation & amortization | $2.3M | $2.6M | −$296K | -11% |
| Share-based compensation | $1.3M | $1.3M | −$32K | -2% |
| Working capital & other | $9.1M | −$9.4M | $18.5M | — |
| Operating cash flow | $1.3M | $18.8M | −$17.5M | -93% |
| Free cash flow (OCF − capex) | $1.2M | $18.5M | −$17.3M | -94% |
| Capital expenditures | $103K | $266K | −$163K | -61% |
Questions
How much did Paysign's revenue grow quarter over quarter in Q2 2026?
Paysign's revenue rose $214K (+0.8%) from $28.0M in Q1 2026 to $28.3M in Q2 2026.
What drove Paysign's revenue change in Q2 2026?
Plasma Industry +$1.3M (+11%); Pharma Industry −$1.0M (-7%); Other Revenue −$48K (-8%).